

［1］Cambria-Kiely JA.Gandhi PJ.Aspirin resistance and genetic polymorphism［J］.J Thromb Thrombolysis，2002，14(1)：51-58. 

［2］Gum PA，Kottke-Marchant K，Poggio ED，et aI.Profile and prevalence of aspirin resistance in patients with cardiovascular disease［J］.Am J Cardiol，2001，88：230-235. 

［3］Mosca L，Appel LJ，Benjamin EJ，et al.Evidence-based guidelines for cardiovascular prevention in women［J］.Circulation，2004，109：672-693. 

［4］Ridker PM，Cook NR，Lee lM，et al.A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women［J］.N Engl J Med，2005，352：1293-1304. 

［5］De Gaetano G.Collaborative Group of the Primarv Prevention Project.Low dose aspirin and vitamln E in people at cardiovascuIar risk：a randomized trialin gene practice［J］.Lancet，2001，357：89-95. 

［6］Nancy R.Aspirin in the primary prevention of cardiovascular disease in the Women’s Health Study：Effect of noncompliance［J］.Eur J Epidemiol，2012，(27)：431-438. 

［7］Berger JS，Roncaglioni MC.Aspirin for the primary prevention of cardiovascular events in women and men：a sex-specific meta-analysis of randomized controlled trials［J］.JAMA，2006，295(3)：306-313. 

［8］Hansson L，Zancheti A.Carruthers SG，et al.Hot Study Group Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension：principal results of the Hypertension Optimal Treatment (HOT)randomized tria1［J］.Lancet，1998，351：176-213. 

［9］Mosca L，Benjamin EJ，Berra K，et al.Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update：a guideline from the American Heart Association［J］.J Am Coll Cardiol，2011，57：1404-1423. 

［10］Pignone M，Alberts MJ，Colwell JA，et al.Aspirin for primary prevention of cardiovascular events in people with diabetes：a positions treatment of the American Diabetes Association，a scientific statement of the American Heart Association，and an expertion sensus document of the American College of Cardiology Foundation［J］.Circulation，2010，121(24)：2694- 2701. 

［11］中华医学会心血管病分会，中国老年学学会心脑血管专业委员会，中国医师协会心血管内科医师分会.心血管疾病防治指南和共识2012［M］.北京：人民卫生出版社，2012：120-122. 

［12］Guidelines：2012 focused update of the ESC Guidelines for the management of atrial fibrillation：an update of the 2010 ESC Guidelines for the management of atrial fibrillation［J］.Eur Heart J，2013，34(36)：2850-2851. 

［13］施仲伟.阿司匹林心血管病一级预防新证据［J］.中国实用内科杂志，2011，31(2)：152-154. 